{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:55:43Z","timestamp":1790319343997,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cmpb.2022.106934","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T11:29:17Z","timestamp":1654255757000},"page":"106934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Considering population variability of electrophysiological models improves the in silico assessment of drug-induced torsadogenic risk"],"prefix":"10.1016","volume":"221","author":[{"given":"Jordi","family":"Llopis-Lorente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Trenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmpb.2022.106934_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1087057115594589","article-title":"A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm","volume":"21","author":"Fermini","year":"2016","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.cmpb.2022.106934_bib0002","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium","volume":"167","author":"Sager","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cmpb.2022.106934_bib0003","doi-asserted-by":"crossref","first-page":"12","DOI":"10.12793\/tcp.2019.27.1.12","article-title":"Introduction to in silico model for proarrhythmic risk assessment under the CiPA initiative","volume":"27","author":"Park","year":"2019","journal-title":"Transl. Clin. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.00958","article-title":"A heart for diversity: simulating variability in cardiac arrhythmia research","volume":"9","author":"Ni","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbiomolbio.2015.12.002","article-title":"Variability in cardiac electrophysiology: using experimentally-calibrated populations of models to move beyond the single virtual physiological human paradigm","volume":"120","author":"Muszkiewicz","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0006","article-title":"The electrogenic Na+\/K+ pump is a key determinant of repolarization abnormality susceptibility in human ventricular cardiomyocytes: a population-based simulation study","volume":"8","author":"Britton","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0007","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/cpt.1647","article-title":"General principles for the validation of proarrhythmia risk prediction models: an extension of the CiPA in silico strategy","volume":"107","author":"Li","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2022.106934_bib0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk","volume":"91","author":"Mirams","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cmpb.2022.106934_bib0009","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cpt.1184","article-title":"Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative","volume":"105","author":"Li","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2022.106934_bib0010","first-page":"2289","article-title":"Assessment of drug proarrhythmicity using artificial neural networks with in silico deterministic model outputs","volume":"0","author":"Yoo","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0011","doi-asserted-by":"crossref","unstructured":"J. Tomek, A. Bueno-Orovio, B. Rodriguez, ToR-ORd-dynCl: an update of the ToR-ORd model of human ventricular cardiomyocyte with dynamic intracellular chloride, BioRxiv. (2020) 127043, doi:10.1101\/2020.06.01.127043.","DOI":"10.1101\/2020.06.01.127043"},{"key":"10.1016\/j.cmpb.2022.106934_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation","volume":"7","author":"O'Hara","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0013","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jcim.0c00201","article-title":"In silico classifiers for the assessment of drug proarrhythmicity","volume":"60","author":"Llopis-Lorente","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cmpb.2022.106934_bib0014","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.01170.2010","article-title":"Ionic mechanisms of electrophysiological properties and repolarization abnormalities in rabbit Purkinje fibers","volume":"300","author":"Corrias","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0015","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00263.2009","article-title":"Impact of ionic current variability on human ventricular cellular electrophysiology","volume":"297","author":"Romero","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0016","unstructured":"D.A. Sampedro, Theoretical analysis of autonomic nervous system effects on cardiac electrophysiology an its relationship with the arrhythmias risk, 2020."},{"key":"10.1016\/j.cmpb.2022.106934_bib0017","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1006\/jmcc.1998.0748","article-title":"Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure","volume":"30","author":"Schmidt","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0018","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2009.09.019","article-title":"A novel computational model of the human ventricular action potential and Ca transient","volume":"48","author":"Grandi","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0019","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.CIR.0000023042.50192.F4","article-title":"Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium","volume":"106","author":"Pieske","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cmpb.2022.106934_bib0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cmpb.2022.106934_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The comprehensive in vitro proarrhythmia assay (CiPA) initiative \u2014 update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.cmpb.2022.106934_bib0022","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/acs.jcim.7b00440","article-title":"In Silico QT and APD prolongation assay for early screening of drug-induced proarrhythmic risk","volume":"58","author":"Romero","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cmpb.2022.106934_bib0023","series-title":"2016 Computing in Cardiology Conference (CinC)","first-page":"869","article-title":"Optimization of an in silico cardiac cell model for proarrhythmia risk assessment","author":"Dutta","year":"2016"},{"key":"10.1016\/j.cmpb.2022.106934_bib0024","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1111\/bph.14786","article-title":"Drug-induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias","volume":"176","author":"Passini","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0025","unstructured":"R. Woosley, K. Romero, W. Heise, Risk Categories for drugs that prolong Qt & induce torsade de pointes (TdP), (n.d.). https:\/\/www.crediblemeds.org\/druglist (accessed December 14, 2021)."},{"key":"10.1016\/j.cmpb.2022.106934_bib0026","series-title":"Heuristics: Intelligent Search Strategies for Computer Problem Solving","author":"Pearl","year":"1984"},{"key":"10.1016\/j.cmpb.2022.106934_bib0027","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/jmri.25791","article-title":"Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high-grade lesions","volume":"47","author":"Corino","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.cmpb.2022.106934_bib0028","article-title":"Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study","volume":"9","author":"Gomez","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cmpb.2022.106934_bib0029","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fphys.2017.00668","article-title":"Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity","volume":"8","author":"Passini","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0030","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/cpt.1184","article-title":"Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative","volume":"105","author":"Li","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cmpb.2022.106934_bib0031","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fphys.2017.00597","article-title":"Quantitative comparison of effects of dofetilide, sotalol, quinidine, and verapamil between human ex vivo trabeculae and in silico ventricular models incorporating inter-individual action potential variability","volume":"8","author":"Britton","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0032","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","article-title":"Drug-induced inhibition and trafficking disruption of ion channels: pathogenesis of QT abnormalities and drug-induced fatal arrhythmias","volume":"12","author":"Cubeddu","year":"2016","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.cmpb.2022.106934_bib0033","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.joad.2015.10.002","article-title":"A review on dronedarone: pharmacological, pharmacodynamic and pharmacokinetic profile","volume":"5","author":"Iram","year":"2016","journal-title":"J. Acute Disease"},{"key":"10.1016\/j.cmpb.2022.106934_bib0034","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2459\/JCM.0b013e3283439746","article-title":"Effects of cilostazol in the heart","volume":"12","author":"Kanlop","year":"2011","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.cmpb.2022.106934_bib0035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0091270011400071","article-title":"Thorough QT\/QTc study of ritonavir-boosted saquinavir following multiple-dose administration of therapeutic and supratherapeutic doses in healthy participants","volume":"52","author":"Zhang","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0036","article-title":"FDA evaluation of cardiac repolarization data for 19 drugs and drug candidates","volume":"79","author":"Cantilena","year":"2006","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/j.cmpb.2022.106934_bib0037","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3389\/fphar.2017.00816","article-title":"Novel two-step classifier for Torsades de Pointes risk stratification from direct features","volume":"8","author":"Parikh","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0038","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: superior to the HERG model in predicting torsade de pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cmpb.2022.106934_bib0039","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cmpb.2022.106934_bib0040","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fphar.2019.01643","article-title":"Blinded in silico drug trial reveals the minimum set of ion channels for torsades de pointes risk assessment","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0041","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/jpet.107.128405","article-title":"Alfuzosin delays cardiac repolarization by a novel mechanism","volume":"324","author":"Lacerda","year":"2008","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.cmpb.2022.106934_bib0042","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5253","article-title":"Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data","volume":"11","author":"Yang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cmpb.2022.106934_bib0043","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cpt.2240","article-title":"Sex-specific classification of drug-induced torsade de pointes susceptibility using cardiac simulations and machine learning","volume":"110","author":"Fogli Iseppe","year":"2021","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/j.cmpb.2022.106934_bib0044","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3389\/fphar.2021.598549","article-title":"Inflammation as a risk factor in cardiotoxicity: an important consideration for screening during drug development","volume":"12","author":"Campana","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0045","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.bpj.2008.10.056","article-title":"Parameter sensitivity analysis in electrophysiological models using multivariable regression","volume":"96","author":"Sobie","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.cmpb.2022.106934_bib0046","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.hrthm.2017.07.026","article-title":"Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: an in silico approach","volume":"14","author":"Paci","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cmpb.2022.106934_bib0047","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/psp4.12573","article-title":"Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions","volume":"10","author":"Varshneya","year":"2021","journal-title":"CPT Pharmacometr. Syst. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114883","article-title":"Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay","volume":"390","author":"Morissette","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0049","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/acs.jcim.9b01085","article-title":"When does the IC 50 accurately assess the blocking potency of a drug?","volume":"2020","author":"Gomis-Tena","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cmpb.2022.106934_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114961","article-title":"A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm","volume":"394","author":"Ridder","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0051","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.vascn.2013.04.007","article-title":"Variability in high-throughput ion-channel screening data and consequences for cardiac safety assessment","volume":"68","author":"Elkins","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.cmpb.2022.106934_bib0052","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12688\/wellcomeopenres.9945.2","article-title":"Hierarchical Bayesian inference for ion channel screening dose-response data","volume":"1","author":"Johnstone","year":"2017","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.cmpb.2022.106934_bib0053","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fphys.2017.00917","article-title":"Uncertainty quantification reveals the importance of data variability and experimental design considerations for in silico proarrhythmia risk assessment","volume":"8","author":"Chang","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0054","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fphys.2017.00616","article-title":"Optimization of an in silico cardiac cell model for proarrhythmia risk assessment","volume":"8","author":"Dutta","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cmpb.2022.106934_bib0055","doi-asserted-by":"crossref","first-page":"E2098","DOI":"10.1073\/pnas.1304382110","article-title":"Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology","volume":"110","author":"Britton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cmpb.2022.106934_bib0056","first-page":"e1482","article-title":"Calibration of ionic and cellular cardiac electrophysiology models","volume":"12","author":"Whittaker","year":"2020","journal-title":"Wiley Interdiscip. Rev."},{"key":"10.1016\/j.cmpb.2022.106934_bib0057","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cpt.367","article-title":"Improved prediction of drug-induced torsades de pointes through simulations of dynamics and machine learning algorithms","volume":"100","author":"Lancaster","year":"2016","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260722003169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260722003169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:21:08Z","timestamp":1759206068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260722003169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":57,"alternative-id":["S0169260722003169"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2022.106934","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considering population variability of electrophysiological models improves the in silico assessment of drug-induced torsadogenic risk","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2022.106934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106934"}}